Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, ISO 9001, USP, BP |
Suitable for: | Elderly, Children, Adult |
State: | Powder |
Purity: | ≦96% |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Name : Erlotinib
Shape : White crystalline powder
Second-line treatment for locally advanced or metastatic non-small cell lung cancer.It has been approved by FDA for use in combination with gemcitabine as a first-line treatment for advanced pancreatic cancer.
Erlotinib is indicated for second-line treatment of locally advanced or metastatic non-small cell lung cancer.It is mainly metabolized by the liver, with 83% excreted in feces and 8% excreted in urine.
Name | CAS | molecular | density |
Erlotinib | 183321-74-6 | C22H23N3O4 | 1.24 |
Suppliers with verified business licenses